DK0746613T3 - Rekombinante humaniserede antistoffer mod FB5 - Google Patents

Rekombinante humaniserede antistoffer mod FB5

Info

Publication number
DK0746613T3
DK0746613T3 DK95913660T DK95913660T DK0746613T3 DK 0746613 T3 DK0746613 T3 DK 0746613T3 DK 95913660 T DK95913660 T DK 95913660T DK 95913660 T DK95913660 T DK 95913660T DK 0746613 T3 DK0746613 T3 DK 0746613T3
Authority
DK
Denmark
Prior art keywords
humanized
antibodies
specific antibodies
provides
specific
Prior art date
Application number
DK95913660T
Other languages
English (en)
Inventor
Francis J Carr
Lloyd J Old
Thomas P Wallace
Wolfgang J Rettig
Pilar Garin-Chesa
William J Harris
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Application granted granted Critical
Publication of DK0746613T3 publication Critical patent/DK0746613T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK95913660T 1994-03-08 1995-03-08 Rekombinante humaniserede antistoffer mod FB5 DK0746613T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20777894A 1994-03-08 1994-03-08

Publications (1)

Publication Number Publication Date
DK0746613T3 true DK0746613T3 (da) 2006-09-25

Family

ID=22771976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95913660T DK0746613T3 (da) 1994-03-08 1995-03-08 Rekombinante humaniserede antistoffer mod FB5

Country Status (8)

Country Link
US (4) US5811522A (da)
EP (1) EP0746613B1 (da)
AT (1) ATE327330T1 (da)
AU (1) AU688880B2 (da)
CA (1) CA2185116A1 (da)
DE (1) DE69535002T2 (da)
DK (1) DK0746613T3 (da)
WO (1) WO1995024483A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342757A (en) * 1992-11-13 1994-08-30 Ludwig Institute For Cancer Research Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
ATE327330T1 (de) * 1994-03-08 2006-06-15 Sloan Kettering Inst Cancer Rekombinante humanisierte antikörper gegen fb5
EA003326B1 (ru) * 1998-12-02 2003-04-24 Пфайзер Продактс Инк. Способ лечения рака
WO2000066155A1 (en) 1999-04-30 2000-11-09 La Jolla Institute For Allergy And Immunology Methods for preventing reactivation of latent virus and controlling virus replication
EP1307557A2 (en) 2000-08-02 2003-05-07 The Johns Hopkins University Endothelial cell expression patterns
US7470428B2 (en) 2002-01-30 2008-12-30 The Brigham And Women's Hospital, Inc. Compositions and methods related to TIM-3, a Th1-specific cell surface molecule
US7501494B2 (en) 2003-01-15 2009-03-10 United Biomedical, Inc. Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection
EP1599503B1 (en) * 2003-03-04 2010-12-29 Kirin Beer Kabushiki Kaisha Endothelial cell specific antibodies and uses thereof
WO2005086713A2 (en) * 2004-03-04 2005-09-22 Kirin Brewery Co., Ltd. Role of human endothelial precursor cells and vascular pericytes tumor in angiogenesis
CN101057145B (zh) * 2004-06-23 2014-10-22 得克萨斯系统大学评议会 使用双粒子复合体检测生物分子的方法和组合物
US20060121541A1 (en) * 2004-12-03 2006-06-08 Luigi Grasso Use of endosialin binding proteins to isolate endosialin positive cells
US7615372B2 (en) 2005-04-22 2009-11-10 Morphotek, Inc. Antibodies with immune effector activity and that internalize in endosialin-positive cells
PL2620451T3 (pl) 2007-04-05 2017-06-30 Morphotek, Inc. Sposoby hamowania wiązania endosjaliny do ligandów
EA200700940A1 (ru) * 2007-04-27 2007-12-28 Петр Генриевич ЛОХОВ Способ получения противоопухолевой вакцины на основе поверхностных антигенов эндотелиальных клеток
US20090010966A1 (en) * 2007-06-21 2009-01-08 Angelica Therapeutics, Inc. Modified diphtheria toxins
EP2268297A4 (en) * 2008-02-29 2011-11-16 Angelica Therapeutics Inc MODIFIED TOXINS
JP5839467B2 (ja) * 2009-03-06 2016-01-06 ユニベルシテ パリ デカルト 癌を治療するための方法
WO2010118203A2 (en) * 2009-04-09 2010-10-14 Morphotek, Inc. Endosialin binding molecules
WO2011060233A1 (en) 2009-11-11 2011-05-19 The Trustees Of The University Of Pennsylvania Anti-tem1 antibodies and uses thereof
WO2013162748A1 (en) * 2012-04-27 2013-10-31 The Trustees Of The University Of Pennsylvania Anti-tumor endothelial marker-1 (tem1) antibody variants and uses thereof
US10059750B2 (en) 2013-03-15 2018-08-28 Angelica Therapeutics, Inc. Modified toxins
JP6716544B2 (ja) 2014-09-16 2020-07-01 ユナイテッド・バイオメディカル・インコーポレーテッドＵｎｉｔｅｄ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ 競合的ｈｉｖ侵入阻害を媒介するｃｄ４に対するモノクローナル抗体によるｈｉｖ感染の処置および機能的治癒
US11292839B2 (en) 2016-08-13 2022-04-05 Ubi Us Holdings, Llc Treatment and sustained virologic remission of HIV infection by antibodies to CD4 in HAART stabilized patients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) * 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5342757A (en) * 1992-11-13 1994-08-30 Ludwig Institute For Cancer Research Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
ATE327330T1 (de) * 1994-03-08 2006-06-15 Sloan Kettering Inst Cancer Rekombinante humanisierte antikörper gegen fb5

Also Published As

Publication number Publication date
WO1995024483A1 (en) 1995-09-14
AU688880B2 (en) 1998-03-19
DE69535002D1 (de) 2006-06-29
DE69535002T2 (de) 2006-12-07
EP0746613A1 (en) 1996-12-11
US6391302B1 (en) 2002-05-21
EP0746613B1 (en) 2006-05-24
US6217868B1 (en) 2001-04-17
US5811522A (en) 1998-09-22
ATE327330T1 (de) 2006-06-15
AU1996495A (en) 1995-09-25
CA2185116A1 (en) 1995-09-14
US6090930A (en) 2000-07-18

Similar Documents

Publication Publication Date Title
DK0746613T3 (da) Rekombinante humaniserede antistoffer mod FB5
DK0749482T3 (da) Rekombinante humaniserede anti-Lewis Y antistoffer
NO175944C (no) Monoklonale antistoffer for anvendelse til in vitro påvisning av tumorassosiert mucinantigen, og hybridomcellelinjer som produserer disse
HUT52153A (en) Process for producing chimeric antibody specific to human tumour antigene
DE69734109D1 (de) Humanisierung von anti-carcinoembryonalen Antigen anti-idiotypischen Antikörper und dessen Verwendung als Tumorvakzin und zur Markierung
FI963393A (fi) Syöpäolosuhteiden määritys MAGE-geeni-ilmennyksellä
SG96535A1 (en) Pharmaceutical composition for the treatment or prevention of a malignant tumor
ES8900247A1 (es) Un metodo de detecion y diagnostico de cancer empleando un nuevo antigeno asociado a un tumor.
NO20004251L (no) Humaniserte anti-CEA monoklonale antistoffer med høy affinitet
DE3784364D1 (de) Tumorassoziiertes antigen.
AU5790390A (en) A novel tumor associated antigen
KR880002543A (ko) 종양의 치료를 위한 단일군항체의 용도
EP0185135A3 (en) Novel monoclonal antibody
JPS6444856A (en) Anti-cancer antigen anti-serum